Evidence map›Paper›PMID 41798870›Full record

ArticleClinical and translational radiation oncology2026

Norwegian consensus guidelines for selection of neuro-oncology patients to proton therapy.

Liv Cathrine Heggebø, Tor-Christian Aase Johannessen, Henriette Magelssen, Mette Sprauten, Hanne Blakstad, Jorunn Brekke, Dorota Goplen, Kirsten Marienhagen, Tora S Solheim, Line Bjorland and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical and translational radiation oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Liv Cathrine HeggebøDepartment of Oncology, Oslo University Hospital, Oslo, Norway.
Tor-Christian Aase JohannessenDepartment of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway.
Henriette MagelssenDepartment of Oncology, Oslo University Hospital, Oslo, Norway.
Mette SprautenDepartment of Oncology, Oslo University Hospital, Oslo, Norway.
Hanne BlakstadDepartment of Oncology, Oslo University Hospital, Oslo, Norway.
Jorunn BrekkeDepartment of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway.
Dorota GoplenDepartment of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway.
Kirsten MarienhagenDepartment of Oncology, University Hospital of North Norway, Tromsø, Norway.
Tora S SolheimCancer Clinic, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.
Line BjorlandDepartment of Oncology, Stavanger University Hospital, Stavanger, Norway.
Petter BrandalDepartment of Oncology, Oslo University Hospital, Oslo, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With the launch of two Norwegian proton facilities, Norwegian Neuro-Oncology Interest Group developed consensus guidelines for selection of neuro-oncology patients to proton therapy. Relevant literature review and nationwide discussions informed the process. An overview of patients offered proton therapy during the first six months of operation was registered.

Indexed as

Brain NeoplasmsGuidelinesOncologyPatient selectionProton therapyRadiotherapy

Identifiers

PMID41798870
PMCPMC12963899

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.